US 10925972
Glycan-dependent immunotherapeutic molecules
granted A61KA61K38/168A61K38/178
Quick answer
US patent 10925972 (Glycan-dependent immunotherapeutic molecules) held by The Regents of the University of California expires Mon Feb 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Feb 23 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K38/168, A61K38/178, A61K47/6849, A61P